ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
dww65
|
48 |
13K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
48
|
13K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
dww65
|
48 |
13K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
48
|
13K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
dww65
|
48 |
13K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
48
|
13K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval for Phase I/II UTI Trial Expansion
|
|
dww65
|
7 |
3.2K |
3 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
7
|
3.2K
|
3
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
dww65
|
2.1K |
625K |
0 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
2.1K
|
625K
|
0
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
dww65
|
2.1K |
625K |
3 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
2.1K
|
625K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 Phase I Clinical Trial Registered on ANZCTR
|
|
dww65
|
17 |
6.8K |
13 |
02/10/21 |
02/10/21 |
ASX - By Stock
|
17
|
6.8K
|
13
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 Phase I Clinical Trial Registered on ANZCTR
|
|
dww65
|
17 |
6.8K |
5 |
01/10/21 |
01/10/21 |
ASX - By Stock
|
17
|
6.8K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
RCE Media
|
|
dww65
|
370 |
105K |
5 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
370
|
105K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
3AW Nasal Spray Tested on Ferrets
|
|
dww65
|
20 |
5.1K |
5 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
20
|
5.1K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Encouraging Results Against SARS-CoV-2 Virus
|
|
dww65
|
81 |
21K |
13 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
81
|
21K
|
13
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
dww65
|
109 |
28K |
0 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
109
|
28K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: HREC Approval to Start Phase I/II Burns Wound Study
|
|
dww65
|
82 |
24K |
4 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
82
|
24K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: HREC Approval to Start Phase I/II Burns Wound Study
|
|
dww65
|
82 |
24K |
1 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
82
|
24K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
dww65
|
41 |
15K |
11 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
41
|
15K
|
11
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
dww65
|
41 |
15K |
2 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
41
|
15K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Investor Presentation
|
|
dww65
|
20 |
8.4K |
1 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
20
|
8.4K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
RCE Media thread
|
|
dww65
|
488 |
139K |
5 |
11/07/20 |
11/07/20 |
ASX - By Stock
|
488
|
139K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
RCE Media thread
|
|
dww65
|
488 |
139K |
6 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
488
|
139K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program
|
|
dww65
|
196 |
55K |
10 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
196
|
55K
|
10
|
|
ASX - By Stock
|
RCE |
Re:
up over 10% on no news
|
|
dww65
|
87 |
21K |
2 |
26/05/20 |
26/05/20 |
ASX - By Stock
|
87
|
21K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
up over 10% on no news
|
|
dww65
|
87 |
21K |
4 |
26/05/20 |
26/05/20 |
ASX - By Stock
|
87
|
21K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Data on RECCE 327 Against Influenza A
|
|
dww65
|
56 |
17K |
5 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
56
|
17K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Data on RECCE 327 Against Influenza A
|
|
dww65
|
56 |
17K |
7 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
56
|
17K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
dww65
|
59 |
18K |
1 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
59
|
18K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
dww65
|
59 |
18K |
7 |
19/04/20 |
19/04/20 |
ASX - By Stock
|
59
|
18K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
dww65
|
59 |
18K |
2 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
59
|
18K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: First-in-Human Clinical Trial Progress Update
|
|
dww65
|
79 |
22K |
1 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
79
|
22K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: First-in-Human Clinical Trial Progress Update
|
|
dww65
|
79 |
22K |
0 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
79
|
22K
|
0
|
|
ASX - By Stock
|
GOR |
Re:
Glowing like gold
|
|
dww65
|
17 |
7.3K |
5 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
17
|
7.3K
|
5
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Investor Presentation February / March 2020
|
|
dww65
|
39 |
1.5M |
1 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
39
|
1.5M
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Investor Presentation February / March 2020
|
|
dww65
|
39 |
1.5M |
1 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
39
|
1.5M
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Media Update
|
|
dww65
|
3.4K |
2.3M |
4 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
3.4K
|
2.3M
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Opening Address at 2019 World Antibiotic Resistance Congress
|
|
dww65
|
57 |
17K |
4 |
12/11/19 |
12/11/19 |
ASX - By Stock
|
57
|
17K
|
4
|
|
ASX - By Stock
|
FLC |
Re:
Ann: FLC Signs LOI to increase China Assembly, and Related MOU
|
|
dww65
|
48 |
22K |
3 |
03/11/19 |
03/11/19 |
ASX - By Stock
|
48
|
22K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4C and commentary
|
|
dww65
|
9 |
3.7K |
3 |
29/04/19 |
29/04/19 |
ASX - By Stock
|
9
|
3.7K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Funding Update
|
|
dww65
|
26 |
13K |
3 |
25/04/19 |
25/04/19 |
ASX - By Stock
|
26
|
13K
|
3
|
|
ASX - By Stock
|
MGX |
Re:
Ann: High Grade Ore Sales Commenced from Koolan Island
|
|
dww65
|
275 |
112K |
2 |
25/04/19 |
25/04/19 |
ASX - By Stock
|
275
|
112K
|
2
|
|
ASX - By Stock
|
FLC |
Re:
Media Update
|
|
dww65
|
3.4K |
2.3M |
17 |
24/03/19 |
24/03/19 |
ASX - By Stock
|
3.4K
|
2.3M
|
17
|
|
ASX - By Stock
|
FLC |
Re:
Media Update
|
|
dww65
|
3.4K |
2.3M |
1 |
02/03/19 |
02/03/19 |
ASX - By Stock
|
3.4K
|
2.3M
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Media Update
|
|
dww65
|
3.4K |
2.3M |
6 |
02/03/19 |
02/03/19 |
ASX - By Stock
|
3.4K
|
2.3M
|
6
|
|
ASX - By Stock
|
FLC |
Re:
Media Update
|
|
dww65
|
3.4K |
2.3M |
2 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
3.4K
|
2.3M
|
2
|
|
ASX - By Stock
|
CTP |
Re:
Centralian Advocate article today
|
|
dww65
|
17 |
6.8K |
1 |
09/09/17 |
09/09/17 |
ASX - By Stock
|
17
|
6.8K
|
1
|
|
ASX - By Stock
|
CTP |
Re:
ND Team Announcement 30 August 2017
|
|
dww65
|
4 |
1.6K |
6 |
30/08/17 |
30/08/17 |
ASX - By Stock
|
4
|
1.6K
|
6
|
|
ASX - By Stock
|
CTP |
Re:
( a humourous ) CTP Horoscope : Persona Grata part two
|
|
dww65
|
10 |
3.0K |
1 |
19/08/17 |
19/08/17 |
ASX - By Stock
|
10
|
3.0K
|
1
|
|
ASX - By Stock
|
CTP |
Re:
Ann: Placement Cleansing Notice
|
|
dww65
|
1 |
812 |
1 |
17/08/17 |
17/08/17 |
ASX - By Stock
|
1
|
812
|
1
|
|
ASX - By Stock
|
CTP |
Re:
Macquarie Group Underwriter?
|
|
dww65
|
20 |
12K |
9 |
16/08/17 |
16/08/17 |
ASX - By Stock
|
20
|
12K
|
9
|
|
ASX - By Stock
|
CTP |
Re:
Oh my goodness!
|
|
dww65
|
45 |
17K |
1 |
08/07/17 |
08/07/17 |
ASX - By Stock
|
45
|
17K
|
1
|
|
ASX - By Stock
|
CTP |
Re:
Old Direction Fanciful Finance
|
|
dww65
|
53 |
18K |
1 |
27/06/17 |
27/06/17 |
ASX - By Stock
|
53
|
18K
|
1
|
|
ASX - By Stock
|
CTP |
Re:
New Direction Team Announced
|
|
dww65
|
78 |
31K |
9 |
22/06/17 |
22/06/17 |
ASX - By Stock
|
78
|
31K
|
9
|
|